SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending as chatter increases around potential government investment in quantum computing firms, driving speculation about the company's future. Community members are discussing the significance of SEALSQ's focus on quantum-resistant chips and its potential alignment with national security priorities. Some traders are anticipating a short squeeze, while others point to the company's strong cash position and strategic partnerships as reasons for optimism.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to a potential breakthrough in quantum computing, with successful tests using AMD chips sparking renewed interest in the sector; community discussions highlight the long-term potential and comparisons to other quantum computing stocks, with some traders pointing to IBM's established market presence; this news arrives ahead of anticipated earnings, creating a focal point for investors.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending due to community discussion around a potential short squeeze, fueled by high borrow rates and perceived low float.  Traders are actively debating short interest data and the potential for a gamma squeeze. Some are encouraged by insider buying, while others express concerns about market manipulation.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending with community members expressing strong bullish sentiment and emphasizing its solid community. Discussions highlight consistent growth and anticipation for a potential surge, particularly within the Solana meme coin ecosystem. Some users are drawing comparisons to other meme coins like $DOGE and $SHIB, with the shared goal that 'we're all gonna make it'.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending as community members discuss the potential impact of a major Pentagon contract and Trump Jr.'s involvement with the company. Bullish sentiment revolves around the expectation of future government contracts and expansion into the private sector, particularly with drones. However, some are skeptical of the contract's immediate significance and question the timing of the news.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending due to positive sentiment following a competitor's drug rejection by the EMA, which strengthens the value of SNDX's pipeline. The community is discussing the potential strategic advantage this gives SNDX in the cGvHD market, while also awaiting a catalyst with an upcoming PDUFA date. Investors are also analyzing the high short interest and potential for a squeeze.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a potential short squeeze fueled by recent news including insider buying and milestone payments from Merck. Community members are discussing the stock's low float and potential for significant upward movement.  However, some traders are wary of potential dilution.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is trending as the community debates its future following earnings, with discussions focusing on revenue guidance, potential impacts from tariffs, and consumer demand for Hoka and UGG brands.  Analysts are weighing in with updated ratings, while some investors are expressing concerns about potential overvaluation and the stock's recent performance. The community is closely watching key support levels and potential buyback activity.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel's stock is trending after a volatile reaction to earnings, with community members debating the impact of the results and future outlook. Discussions range from potential short squeezes and market manipulation to the company's long-term turnaround and government support, with some traders expressing frustration over the stock's price action despite positive news.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as it makes a move into prediction markets with the acquisition of Railbird, aiming to expand its reach beyond sports betting. The community is debating the strategic implications of this acquisition, particularly its potential impact on competition with existing prediction platforms and relationships with states already offering legalized sports betting. Some traders express concern about the company's timing relative to competitors, while others anticipate a bullish reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains?

Arcturus Therapeutics (ARCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?

The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Anika (ANIK) Upgraded to Buy: Here's What You Should Know

Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates

uniQure (QURE) delivered earnings and revenue surprises of +22.47% and -26.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?

Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates

Shares of Anika Therapeutics ($ANIK), which provides early intervention for orthopedic care, slipped 3.39% on Friday, a day after the company’s results fell short of Wall Street estimates even as the retail sentiment stayed cautious.Anika has beaten earnings estimates three times in the last four quarters. For the third quarter, the company posted earnings per share (EPS) of - $0.25, missing the consensus estimate of $0.09. Its net loss widened to $29.9 million from $6.6 million in the year-ago period. The company’s reported revenues of $38.75 million were 7.91% below consensus estimates.It also updated its guidance on its 2024 adjusted earnings before interest, taxes, depreciation and amortization, or Ebitda, expecting it to fall between $16 and $18 million.Barrington analyst Michael Petusky has cut the firm’s price target to $25 from $37&nbsp; while maintaining an “Outperform” rating on its stock following the results, The Fly.com <a target="_blank" rel="noopener noreferrer nofollow" href="https://thefly.com/news.php?symbol=ANIK">reported,</a> citing “weakening OA pain volumes and softer pricing” that collectively drove its more pessimistic outlook.Petusky’s price target is based on the company’s FY25 adjusted EBITDA estimate plus $50M of value it adds for the company’s “two potential needle-mover products” – Cingal and Hyalofast – that have completed “pivotal trials” but are yet to receive regulatory approval, the report added.Retail sentiment has remained ‘neutral’ on the stock even as the message volumes soared into the ‘extremely high’ zone.<figure class="image"><img style="aspect-ratio:1304/306;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_11_02_at_1_34_53_AM_d6d50fb11b.png" alt="Screenshot 2024-11-02 at 1.34.53 AM.png" width="1304" height="306"><figcaption>ANIK sentiment meter and message volumes on Nov 1 as of 4:36 pm ET</figcaption></figure>Anika also announced the sale of its Arthrosurface business for $10 million, and said it was actively pursuing the sale of another division, Parcus Medical, as part of its efforts to refocus on its strategy. The sale will “optimize” the company's capital allocation and redouble efforts on its profitable core hyaluronic acid (HA) technology and Regenerative Solutions portfolios.Some users were optimistic about its long-term prospects despite shares being down 27% year-to-date.<stembedurl>https://stocktwits.com/Aigner_Andreas/message/582406016</stembedurl>For updates and corrections, email newsroom@stocktwits.com

he company’s reported revenues of $38.75 million were 7.91% below consensus estimates. | Image source: Pixabay

Retail Investors Remain Cautious After Anika’s Q3 Earnings Misses Estimates

Barrington analyst Michael Petusky has cut the firm’s price target to $25 from $37 

Equity

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics PR Newswire WEST BRIDGEWATER, Mass...

Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights

Latest Ratings for ANIK
 DateFirmActionFromTo Mar 2022Stephens & Co.DowngradesOverweightEqual-Weight Nov 2021Stephens & Co.Initiates Coverage OnOverweight Jul 2021UBSInitiates Coverage OnNeutral...

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

ANIK
Anika Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIK News

ANIKAnika Therapeutics Inc.